Co-Authors
This is a "connection" page, showing publications co-authored by Pierre-Edouard Fournier and Hervé Tissot-Dupont.
Connection Strength
0.779
-
Evaluation of the Panbio COVID-19 Rapid Antigen Detection Test Device for the Screening of Patients with COVID-19. J Clin Microbiol. 2021 01 21; 59(2).
Score: 0.231
-
Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19. J Clin Virol. 2020 12; 133:104682.
Score: 0.228
-
Implementation of an in-house real-time reverse transcription-PCR assay for the rapid detection of the SARS-CoV-2 Marseille-4 variant. J Clin Virol. 2021 06; 139:104814.
Score: 0.059
-
Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: An investigational study. Travel Med Infect Dis. 2021 Mar-Apr; 40:101980.
Score: 0.058
-
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791.
Score: 0.056
-
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
Score: 0.055
-
Marseille scoring system for empiric treatment of infective endocarditis. Eur J Clin Microbiol Infect Dis. 2018 May; 37(5):841-849.
Score: 0.047
-
Mycoplasma genitalium, an agent of reemerging sexually transmitted infections. APMIS. 2017 Oct; 125(10):916-920.
Score: 0.045